← FDA DRUG APPROVALS

FDA ANDA · ANDA074542

GLIPIZIDE

Sponsor: CHARTWELL RX

APPLICATION
ANDA074542
TYPE
ANDA
ORIGINAL APPROVAL
1995-06-20
LATEST ACTION
2000-03-27
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

GLIPIZIDEDiscontinued
GLIPIZIDE 10MG · TABLET · ORAL
GLIPIZIDEDiscontinued
GLIPIZIDE 5MG · TABLET · ORAL

Approval history

2000-03-27Manufacturing (CMC) · Supplement 1AP
1995-06-20OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →